Oasmia Pharmaceutical AB Price Prediction
OASMYDelisted Stock | USD 0.06 0.00 0.00% |
Oversold Vs Overbought
30
Oversold | Overbought |
Using Oasmia Pharmaceutical hype-based prediction, you can estimate the value of Oasmia Pharmaceutical AB from the perspective of Oasmia Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Oasmia Pharmaceutical to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Oasmia because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Oasmia Pharmaceutical after-hype prediction price | USD 0.06 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Oasmia |
Oasmia Pharmaceutical After-Hype Price Prediction Density Analysis
As far as predicting the price of Oasmia Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Oasmia Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Oasmia Pharmaceutical, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
Oasmia Pharmaceutical Estimiated After-Hype Price Volatility
In the context of predicting Oasmia Pharmaceutical's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Oasmia Pharmaceutical's historical news coverage. Oasmia Pharmaceutical's after-hype downside and upside margins for the prediction period are 0.06 and 0.06, respectively. We have considered Oasmia Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Oasmia Pharmaceutical is very steady at this time. Analysis and calculation of next after-hype price of Oasmia Pharmaceutical is based on 3 months time horizon.
Oasmia Pharmaceutical Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Oasmia Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Oasmia Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Oasmia Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 5 Events / Month | Uncertain |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.06 | 0.06 | 0.00 |
|
Oasmia Pharmaceutical Hype Timeline
Oasmia Pharmaceutical is now traded for 0.06. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Oasmia is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on Oasmia Pharmaceutical is about 0.0%, with the expected price after the next announcement by competition of 0.06. The company has price-to-book ratio of 0.68. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Oasmia Pharmaceutical last dividend was issued on the 25th of March 2022. The entity had 1673:1223 split on the 15th of November 2019. Assuming the 90 days horizon the next expected press release will be uncertain. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.Oasmia Pharmaceutical Related Hype Analysis
Having access to credible news sources related to Oasmia Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Oasmia Pharmaceutical's future price movements. Getting to know how Oasmia Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Oasmia Pharmaceutical may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
VLRS | Volaris | 0.46 | 10 per month | 1.51 | 0.16 | 4.46 | (2.63) | 9.30 | |
DAL | Delta Air Lines | 0.50 | 5 per month | 1.34 | 0.18 | 4.11 | (2.91) | 10.43 | |
CPA | Copa Holdings SA | 0.76 | 10 per month | 2.68 | (0.03) | 3.72 | (2.73) | 17.31 | |
VSCO | Victorias Secret Co | 2.19 | 8 per month | 1.64 | 0.32 | 6.62 | (3.13) | 13.33 | |
GOOS | Canada Goose Holdings | 0.17 | 10 per month | 0.00 | (0.05) | 4.31 | (4.19) | 16.44 | |
ALK | Alaska Air Group | (0.16) | 7 per month | 1.05 | 0.23 | 4.57 | (2.76) | 14.50 | |
GAP | The Gap, | 0.12 | 11 per month | 1.80 | 0.07 | 5.26 | (3.38) | 16.96 |
Oasmia Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine Oasmia price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Oasmia using various technical indicators. When you analyze Oasmia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About Oasmia Pharmaceutical Predictive Indicators
The successful prediction of Oasmia Pharmaceutical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Oasmia Pharmaceutical AB, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Oasmia Pharmaceutical based on analysis of Oasmia Pharmaceutical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Oasmia Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Oasmia Pharmaceutical's related companies.
Story Coverage note for Oasmia Pharmaceutical
The number of cover stories for Oasmia Pharmaceutical depends on current market conditions and Oasmia Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Oasmia Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Oasmia Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Oasmia Pharmaceutical Short Properties
Oasmia Pharmaceutical's future price predictability will typically decrease when Oasmia Pharmaceutical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Oasmia Pharmaceutical AB often depends not only on the future outlook of the potential Oasmia Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oasmia Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 448.4 M | |
Shares Float | 134.6 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Oasmia Pink Sheet
If you are still planning to invest in Oasmia Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oasmia Pharmaceutical's history and understand the potential risks before investing.
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |